Cytokinetics Says 58 in ALS Trial Got Placebo in Error | #ALS AWARENESS #LouGehrigsDisease #PARKINSONS | Scoop.it
Cytokinetics Inc. is evaluating the costs and timing of a clinical trial for its amyotrophic lateral sclerosis treatment after some patients were given a placebo by mistake. The shares fell as much as 8.8 percent.